Alerts will be sent to your verified email
Verify Email
BPLPHARMA
|
Bharat Parenterals
|
Anuh Pharma
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.41 % | 0.0 | 1.93 % |
|
Financials
|
|||
|
5 yr Average ROE
|
12.73 % | 15.87 % | 15.94 % |
|
5yr average Equity Multiplier
|
1.76 | 1.62 | 1.3 |
|
5yr Average Asset Turnover Ratio
|
0.86 | 1.35 | 0.84 |
|
5yr Avg Net Profit Margin
|
8.73 % | 7.23 % | 14.61 % |
|
Price to Book
|
2.96 | 2.71 | 1.62 |
|
P/E
|
0.0 | 19.18 | 12.6 |
|
5yr Avg Cash Conversion Cycle
|
122.06 Days | 42.81 Days | 24.49 Days |
|
Inventory Days
|
46.56 Days | 50.87 Days | 42.89 Days |
|
Days Receivable
|
179.99 Days | 111.12 Days | 90.22 Days |
|
Days Payable
|
95.97 Days | 117.6 Days | 111.35 Days |
|
5yr Average Interest Coverage Ratio
|
22.68 | 48.66 | 58.2 |
|
5yr Avg ROCE
|
16.02 % | 21.17 % | 20.48 % |
|
5yr Avg Operating Profit Margin
|
11.16 % | 10.21 % | 18.48 % |
|
5 yr average Debt to Equity
|
0.26 | 0.02 | 0.0 |
|
5yr CAGR Net Profit
|
-9.67 % | 10.73 % | 12.65 % |
|
5yr Average Return on Assets
|
8.0 % | 9.84 % | 12.28 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.19 % | 69.92 % | 49.78 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-6.65 % | -0.67 % | 5.7 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bharat Parenterals
|
Anuh Pharma
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|